Abstract
Purposes
To develop multifunctional RGD-decorated poly(ethylene oxide)-b-poly(ester) based micelles and assess their pH-triggered core degradation and targeted drug release in tumor cells that overexpress RGD receptors.
Methods
Novel poly(ethylene oxide)-b-poly(ε-caprolactone) (PEO-b-PCL) based copolymers modified with RGD ligands on PEO and pendent functional groups on PCL, i.e., GRGDS-PEO-b-poly(α-benzylcarboxylate-ε-caprolactone) (GRGDS-PEO-b-PBCL) and GRGDS-PEO-b-poly(α-carboxyl-ε-caprolactone) (GRGDS-PEO-b-PCCL), were synthesized. Chemical conjugation of doxorubicin (DOX) to PCCL core produced GRGDS-PEO-b-P(CL-DOX) micellar conjugates, while GRGDS-PEO-b-PBCL were used to physically encapsulate DOX. For both systems, micellar core degradation, drug release, intracellular drug uptake/disposition, and cytotoxicity against B16F10 metastatic cells were investigated.
Results
The PBCL and P(CL-DOX) cores were found resistant to degradation in pH 7.2, but showed 10% and 40% loss in core molecular weight in pH 5.0 within 144 h, respectively. Preferential release of DOX and DOX derivatives from PBCL and P(CL-DOX) cores was noted in pH 5.0, respectively. The GRGDS-modified micelles showed enhanced cellular internalization through endocytosis, increased intracellular DOX release, nuclear localization, and improved cytotoxicity against metastatic B16F10 cells compared to their unmodified counterparts.
Conclusions
The results clearly suggest a promise for the development of multifunctional polymeric micelles with RGD ligand decorated shell and endosomal pH-triggered degradable core for selective DOX delivery to metastatic cancer cells.
Similar content being viewed by others
References
R. Duncan. Polymer conjugates as anticancer nanomedicines. Nat. Rev. 6:688–701 (2006).
R. Duncan. The dawning era of polymer therapeutics. Nat. Rev. 2:347–360 (2003).
M. Ferrari. Cancer nanotechnology: opportunities and challenges. Nat. Rev. Cancer. 5:161–171 (2005) doi:10.1038/nrc1566.
A. Mahmud, X. B. Xiong, and A. Lavasanifar. Novel self-associating poly(ethylene oxide)-block-poly(epsilon-caprolactone) block copolymers with functional side groups on the polyester block for drug delivery. Macromolecules.. 39:9419–9428 (2006) doi:10.1021/ma0613786.
A. Lavasanifar, J. Samuel, and G. S. Kwon. Poly(ethylene oxide)-block-poly(L-amino acid) micelles for drug delivery. Adv. Drug Deliv. Rev. 54:169–190 (2002) doi:10.1016/S0169–409X(02)00015-7.
K. Kataoka, A. Harada, and Y. Nagasaki. Block copolymer micelles for drug delivery: design, characterization and biological significance. Adv. Drug Deliv. Rev. 47:113–131 (2001) doi:10.1016/S0169-409X(00)00124-1.
A. Mahmud, X. B. Xiong, H. M. Aliabadi, and A. Lavasanifar. Polymeric micelles for drug targeting. J. Drug. Target. 15:553–584 (2007) doi:10.1080/10611860701538586.
A. Mahmud, X. B. Xiong, and A. Lavasanifar. Self-associating poly(ethylene oxide)-block-poly(ε-caprolactone) copolymers with carboxyl, benzyl carboxylate and doxorubicin side group: Novel micellar nano-containers and drug conjugates. Eur. J. Pharm. Biopharm., in press (2008).
D. G. Stupackand, and D. A. Cheresh. Integrins and angiogenesis. Curr. Top. Dev. Biol. 64:207–238 (2004) doi:10.1016/S0070-2153(04)64009-9.
J. D. Hoodand, and D. A. Cheresh. Role of integrins in cell invasion and migration. Nat. Rev. 2:91–100 (2002).
J. A. Varnerand, and D. A. Cheresh. Integrins and cancer. Curr. Opin. Cell Biol. 8:724–730 (1996) doi:10.1016/S0955-0674(96)80115-3.
Y. Bae, W. D. Jang, N. Nishiyama, S. Fukushima, and K. Kataoka. Multifunctional polymeric micelles with folate-mediated cancer cell targeting and pH-triggered drug releasing properties for active intracellular drug delivery. Mol. Biosyst. 1:242–250 (2005) doi:10.1039/b500266d.
Y. Bae, N. Nishiyama, and K. Kataoka. In vivo antitumor activity of the folate-conjugated pH-sensitive polymeric micelle selectively releasing adriamycin in the intracellular acidic compartments. Bioconjug. Chem. 18:1131–1139 (2007) doi:10.1021/bc060401p.
N. D. Scott, J. F. Walker, and V. L. Hansley. Sodium naphthalene I A new method for the preparation of addition compounds of alkali metals and polycyclic aromatic hydrocarbons. J. Am. Chem. Soc. 58:2442–2444 (1936) doi:10.1021/ja01303a022.
C. Scholz, M. Iijima, Y. Nagasaki, and K. Kataoka. A novel reactive polymeric micelle with aldehyde groups on its surface. Macromolecules. 28:7295–7297 (1995) doi:10.1021/ma00125a040.
A. Mahmudand, and A. Lavasanifar. The effect of block copolymer structure on the internalization of polymeric micelles by human breast cancer cells. Colloids. Surf. B. Biointerfaces. 45:82–89 (2005) doi:10.1016/j.colsurfb.2005.07.008.
X. B. Xiong, A. Mahmud, H. Uludag, and A. Lavasanifar. Conjugation of arginine-glycine-aspartic acid peptides to poly(ethylene oxide)-b-poly(epsilon-caprolactone) micelles for enhanced intracellular drug delivery to metastatic tumor cells. Biomacromolecules. 8:874–884 (2007) doi:10.1021/bm060967g.
A. Lavasanifar, J. Samuel, and G. S. Kwon. The effect of alkyl core structure on micellar properties of poly(ethylene oxide)-block-poly(L-aspartamide) derivatives. Colloids. Surf. B. Biointerfaces. 22:115–126 (2001) doi:10.1016/S0927-7765(01)00147-3.
R. Karinaga, K. Koumoto, M. Mizu, T. Anada, S. Shinkai, and K. Sakurai. PEG-appended beta-(1–>3)-D-glucan schizophyllan to deliver antisense-oligonucleotides with avoiding lysosomal degradation. Biomaterials. 26:4866–4873 (2005) doi:10.1016/j.biomaterials.2004.11.031.
M. Oba, S. Fukushima, N. Kanayama, K. Aoyagi, N. Nishiyama, H. Koyama, and K. Kataoka. Cyclic RGD peptide-conjugated polyplex micelles as a targetable gene delivery system directed to cells possessing alpha(v)beta(3) and alpha(v)beta(5) Integrins. Bioconjug. Chem. 18:1415–1423 (2007).
Y. Yamamoto, Y. Nagasaki, M. Kato, and K. Kataoka. Surface charge modulation of poly(ethylene glycol)-poly(D, L-lactide) block copolymer micelles: conjugation of charged peptides. Colloid. Surface B. 16:135–146 (1999) doi:10.1016/S0927-7765(99)00065-X.
Y. Gengand, and D. E. Discher. Hydrolytic degradation of poly(ethylene oxide)-block-polycaprolactone worm micelles. J. Am. Chem. Soc. 127:12780–12781 (2005) doi:10.1021/ja053902e.
G. S. Kwon, M. Yokoyama, T. Okano, Y. Sakurai, and K. Kataoka. Biodistribution of micelle-forming polymer-drug conjugates. Pharm. Res. 10:970–974 (1993) doi:10.1023/A:1018998203127.
R. Pasqualini, E. Koivunen, and E. Ruoslahti. Peptides in cell adhesion: powerful tools for the study of integrin-ligand interactions. Braz. J. Med. Biol. Res. 29:1151–1158 (1996)
E. Ruoslahti. RGD and other recognition sequences for integrins. Annu. Rev. Cell. Dev. Biol. 12:697–715 (1996) doi:10.1146/annurev.cellbio.12.1.697.
N. Nasongkla, X. Shuai, H. Ai, B. D. Weinberg, J. Pink, D. A. Boothman, and J. Gao. cRGD-functionalized polymer micelles for targeted doxorubicin delivery. Angew. Chem. Int. Ed. Engl. 43:6323–6327 (2004) doi:10.1002/anie.200460800.
X. B. Xiong, Y. Huang, W. L. Lu, X. Zhang, H. Zhang, T. Nagai, and Q. Zhang. Enhanced intracellular delivery and improved antitumor efficacy of doxorubicin by sterically stabilized liposomes modified with a synthetic RGD mimetic. J. Control Release. 107:262–275 (2005) doi:10.1016/j.jconrel.2005.03.030.
X. B. Xiong, Y. Huang, W. L. Lu, H. Zhang, X. Zhang, and Q. Zhang. Enhanced intracellular uptake of sterically stabilized liposomal Doxorubicin in vitro resulting in improved antitumor activity in vivo. Pharm. Res. 22:933–939 (2005) doi:10.1007/s11095-005-4588-x.
W. Arap, R. Pasqualini, and E. Ruoslahti. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science. 279:377–380 (1998) doi:10.1126/science.279.5349.377.
K. D. Cowden Dahl, S. E. Robertson, V. M. Weaver, and M. C. Simon. Hypoxia-inducible factor regulates alphavbeta3 integrin cell surface expression. Mol. Biol. Cell. 16:1901–1912 (2005) doi:10.1091/mbc.E04-12-1082.
M. J. Humphries, K. M. Yamada, and K. Olden. Investigation of the biological effects of anti-cell adhesive synthetic peptides that inhibit experimental metastasis of B16-F10 murine melanoma cells. J. Clin. Invest. 81:782–790 (1988) doi:10.1172/JCI113384.
M. Yokoyama, M. Miyauchi, N. Yamada, T. Okano, Y. Sakurai, K. Kataoka, and S. Inoue. Characterization and anticancer activity of the micelle-forming polymeric anticancer drug adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer. Cancer Res. 50:1693–1700 (1990).
F. Greco, M. J. Vicent, S. Gee, A. T. Jones, J. Gee, R. I. Nicholson, and R. Duncan. Investigating the mechanism of enhanced cytotoxicity of HPMA copolymer-Dox-AGM in breast cancer cells. J. Control Release. 117:28–39 (2007) doi:10.1016/j.jconrel.2006.10.012.
Y. Luo, N. J. Bernshaw, Z. R. Lu, J. Kopecek, and G. D. Prestwich. Targeted delivery of doxorubicin by HPMA copolymer-hyaluronan bioconjugates. Pharm. Res. 19:396–402 (2002) doi:10.1023/A:1015170907274.
Acknowledgements
This study was supported by the Natural Sciences and Engineering Council of Canada (NSERC) grant Nos. G121210926 and G121220086. AM was supported by Rx and D HRF/CIHR graduate student research scholarship.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Xiong, XB., Mahmud, A., Uludağ, H. et al. Multifunctional Polymeric Micelles for Enhanced Intracellular Delivery of Doxorubicin to Metastatic Cancer Cells. Pharm Res 25, 2555–2566 (2008). https://doi.org/10.1007/s11095-008-9673-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11095-008-9673-5